Literature DB >> 19700318

O-Spiro C-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

Baihua Xu1, Binhua Lv, Yan Feng, Ge Xu, Jiyan Du, Ajith Welihinda, Zelin Sheng, Brian Seed, Yuanwei Chen.   

Abstract

Two series of O-spiro C-aryl glucosides were synthesized and tested for inhibition of hSGLT1 and hSGLT2. 6'-O-Spiro C-aryl glucosides exhibited potent in vitro hSGLT2 inhibitory activity but 2'-O-spiro C-aryl glucosides showed no in vitro hSGLT2 inhibitory activity at a screening concentration of 1microM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700318     DOI: 10.1016/j.bmcl.2009.08.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  2-[4-Chloro-3-(4-ethoxy-benz-yl)phen-yl]-1,3-dithiane.

Authors:  Brian Samas; Cathy Préville; Benjamin A Thuma; Vincent Mascitti
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-19

Review 2.  SGLT inhibitors as antidiabetic agents: a comprehensive review.

Authors:  Rahul P Kshirsagar; Abhishek A Kulkarni; Rashmi S Chouthe; Shahebaaz K Pathan; Hemant D Une; G Bhanuprakash Reddy; Prakash V Diwan; Siddique Akber Ansari; Jaiprakash N Sangshetti
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 4.036

3.  Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity.

Authors:  Shiliang Li; Guoqin Luan; Xiaoli Ren; Wenlin Song; Liuxin Xu; Minghao Xu; Junsheng Zhu; Dong Dong; Yanyan Diao; Xiaofeng Liu; Lili Zhu; Rui Wang; Zhenjiang Zhao; Yufang Xu; Honglin Li
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.